Amexdrug Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by AMIN JACK, was filed 19 Nov 2009.
Amexdrug Corp: what insiders have been doing
This page follows insider dealings at Amexdrug Corp as filed with SEC (Form 4). No insider at Amexdrug Corp has published a filing in the past twelve months. The most recent one dates from 19 November 2009.
Looking back to 2009, when coverage begins, insiders filed 8 purchases and no sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -30.9%Entry US$0.11 · Close at T+365 US$0.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- 500 shares@ US$1.01Common Stock, $0.001 parSEC:0001096906-09-001417:0Canonical exit: 16 Sept 2009 (T+90)
- 500 shares@ US$1.01Common Stock, $0.001 parSEC:0001096906-09-001417:1Canonical exit: 17 Sept 2009 (T+90)
- 1,500 shares@ US$1.10Common Stock, $0.001 parSEC:0001096906-09-001417:2Canonical exit: 21 Sept 2009 (T+90)
- 500 shares@ US$1.40Common Stock, $0.001 parSEC:0001096906-09-001417:3Canonical exit: 24 Sept 2009 (T+90)
- 100 shares@ US$2.00Common Stock, $0.001 parSEC:0001096906-09-001417:4Canonical exit: 4 Oct 2009 (T+90)
- 1,000 shares@ US$1.35Common Stock, $0.001 parSEC:0001096906-09-001417:5Canonical exit: 5 Nov 2009 (T+90)
- 2 shares@ US$1.35Common Stock, $0.001 parSEC:0001096906-09-001417:6Canonical exit: 7 Dec 2009 (T+90)
- 100 shares@ US$1.35Common Stock, $0.001 parSEC:0001096906-09-001417:7Canonical exit: 15 Dec 2009 (T+90)
8 of 8 declarations
About Amexdrug Corp
Amexdrug Corp is a publicly traded company on NASDAQ, specializing in the pharmaceutical sector. It focuses on the development and distribution of innovative medications.
